Clinical Trial Update: Linagliptin's Effect on CD34+ Stem Cells [Phase 4]

View source ↗

Summary

Phase 4 trial assessing linagliptin's effects on CD34+ stem cells in adults with type 2 diabetes and impaired renal function has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Impaired Renal Function
• Type 2 Diabetes Mellitus

Drugs mentioned

• Linagliptin (linagliptin)

Snippet

Sponsor: George Washington University | Conditions: Type 2 Diabetes, Impaired Renal Function | Phase 4 | Status: COMPLETED | Results posted: 2023-01-19